Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,801 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia

NCT01156883

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Complesso Ospedaliero S. Giovanni Addolorata Roma, (RM), Italy
  • Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy
  • USL 8 - Ospedale S.Donato Arezzo, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
View all 43 locations
View Trial Details
Completed

Childhood Acute Lymphoblastic Leukaemia: Follow-Up

NCT03545659

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus N, Denmark
  • Department of Paediatrics and Adolescent Medicine, Turku University Hospital Turku, Finland
  • The National University Hospital of Iceland Reykjavik, Iceland
  • Department of Childhood Oncology, University Hospital Tromsø Tromsø, Norway
View Trial Details
Completed

A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351

NCT03555955

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +18 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Northside Hospital - Blood and Bone Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NCT00171249

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +23 more
Locations
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • New York Presbyterian Hospital New York, United States
  • Oregon Health & Sciences University Portland, Oregon, United States
  • MD Anderson Cancer Center, University of Texas Houston, Texas, United States
View Trial Details
Completed

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

NCT00171223

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +20 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • H. Lee Moffet Cancer Center & Research Institute/Univ of South Florida Tampa, Florida, United States
  • Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 28 locations
View Trial Details

Related conditions